Gerald John Allen

Title: Gerald John Allen: Innovator in Agglutination Assays

Introduction

Gerald John Allen is a notable inventor based in Caythorpe, GB. He has made significant contributions to the field of diagnostics through his innovative patents. With a total of 2 patents, Allen has focused on developing methods that enhance the sensitivity and effectiveness of agglutination assays.

Latest Patents

Allen's latest patents include the "Agglutination Assay" and the "Saturation Assay." The Agglutination Assay relates to methods of assaying small analytes with few epitopes. This invention utilizes hub moieties to bind multiple analytes, along with a further moiety that can bind to a detectable particle. This approach allows for the formation of stable agglutinated complexes, which can be used in various assay formats. The Saturation Assay provides a modified method that measures the free or unbound labeled reagent fraction. This assay employs trapping zones to concentrate the unbound fraction, thereby avoiding loss of sensitivity, and is preferably a membrane assay.

Career Highlights

Gerald John Allen is associated with Platform Diagnostics Limited, where he applies his expertise in developing diagnostic tools. His work has been instrumental in advancing the capabilities of diagnostic assays, making them more reliable and efficient.

Collaborations

Some of his notable coworkers include Carolyn Jennifer Ruddell and Douglas Robert Evans. Their collaboration has contributed to the innovative environment at Platform Diagnostics Limited.

Conclusion

Gerald John Allen's contributions to the field of diagnostics through his patents reflect his commitment to innovation. His work continues to influence the development of more effective diagnostic methods.